First Time Loading...

Chembio Diagnostics Inc
NASDAQ:CEMI

Watchlist Manager
Chembio Diagnostics Inc Logo
Chembio Diagnostics Inc
NASDAQ:CEMI
Watchlist
Price: 0.455 USD 0.22% Market Closed
Updated: May 2, 2024

Chembio Diagnostics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chembio Diagnostics Inc
Operating Income Peer Comparison

Comparables:
HAE
COO
XRAY
ALGN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Chembio Diagnostics Inc
NASDAQ:CEMI
Operating Income
-$20.4m
CAGR 3-Years
-17%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Operating Income
$199.3m
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
4%
Cooper Companies Inc
NYSE:COO
Operating Income
$536.7m
CAGR 3-Years
17%
CAGR 5-Years
5%
CAGR 10-Years
5%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Operating Income
$296m
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Align Technology Inc
NASDAQ:ALGN
Operating Income
$663.9m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
14%

See Also

What is Chembio Diagnostics Inc's Operating Income?
Operating Income
-20.4m USD

Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Operating Income amounts to -20.4m USD.

What is Chembio Diagnostics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-26%

Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Chembio Diagnostics Inc have been -17% over the past three years , -26% over the past five years .